However, Wedbush’s team said Musk has a good track record of balancing multiple initiatives and accelerating innovation at Tesla. Put simply, Wedbush views these as containable brand issues that ...

Check Out Our Latest Analysis on Arcus Biosciences Arcus Biosciences Trading Up 3.0 % NYSE:RCUS opened at $11.06 on Friday. The company has a 50-day moving average price of $13.92 and a 200-day ...

Read Our Latest Research Report on CMRX Chimerix Stock Up 1.8 % Chimerix stock opened at $5.17 on Wednesday. The company has a market capitalization of $464.99 million, a P/E ratio of -5.50 and a ...

Investing.com -- Tesla's stock has faced continued pressure in 2025, but Wedbush analysts remain bullish, maintaining their Outperform rating and $550 price target on the stock. While concerns ...

Wedbush analyst Dan Ives has been one of the early backers of Palantir. Safe to say, his pick has been a success. Now, as Ives continues to remain bullish on the company, he is eyeing another ...

Wedbush made a splash on Tuesday with the announcement that it was entering the ever-growing exchange-traded fund market. With more than 7K ETFs listed globally, collectively managing over $10T in ...

LOS ANGELES, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Wedbush, a Los Angeles-based financial services firm with global reach, and a legacy of innovation and client-focused investment solutions ...

LOS ANGELES, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Wedbush, a Los Angeles-based financial services firm with global reach, and a legacy of innovation and client-focused investment solutions, introduces ...

Earlier this week, investment bank Wedbush identified Palantir Technologies (PLTR) as a top pick for the AI revolution in 2025. Wedbush expects Palantir’s AI platform to gain traction among ...